Literature DB >> 10760688

Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3.

Y Utada1, S Haga, T Kajiwara, F Kasumi, G Sakamoto, Y Nakamura, M Emi.   

Abstract

Allelic losses on the long arm of human chromosome 6 are frequently observed in cancers of the ovary, prostate, and breast. To identify the locations of putative tumor suppressor genes on 6q, we examined 192 primary breast cancers for patterns of allelic loss at 16 polymorphic microsatellite loci distributed along this chromosome arm. Allelic losses at one or more loci were observed in 105 (55%) of the tumors examined. Detailed deletion mapping with appropriate yeast artificial chromosome (YAC) contigs identified two distinct commonly deleted regions; one was confined to a 1-cM interval at 6q21 flanked by D6S1040 and D6S262 and the other to a 1-cM interval at 6q25.3 flanked by D6S305 and D6S411. Allelic losses at 6q21 were more frequent in invasive solid tubular and scirrhous carcinomas than in tumors of less aggressive histologic types (P = 0.0006). Allelic loss at 6q25.3 was associated with loss of progesterone receptor (P = 0.0256). Our results suggest the presence of two tumor suppressor genes for breast cancer on 6q that are likely to be associated with tumor progression and / or loss of hormonal dependency.

Entities:  

Mesh:

Year:  2000        PMID: 10760688      PMCID: PMC5926368          DOI: 10.1111/j.1349-7006.2000.tb00944.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  39 in total

1.  Accumulation of genetic alterations and progression of primary breast cancer.

Authors:  T Sato; F Akiyama; G Sakamoto; F Kasumi; Y Nakamura
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

2.  Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21.

Authors:  T Sherratt; C Morelli; J M Boyle; C J Harrison
Journal:  Chromosome Res       Date:  1997-04       Impact factor: 5.239

3.  Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

Authors:  S A Chappell; T Walsh; R A Walker; J A Shaw
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Identification of two distinct regions of deletion at 6q in gastric carcinoma.

Authors:  L Queimado; R Seruca; A Costa-Pereira; S Castedo
Journal:  Genes Chromosomes Cancer       Date:  1995-09       Impact factor: 5.006

5.  Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations.

Authors:  Y Harada; T Katagiri; I Ito; F Akiyama; G Sakamoto; F Kasumi; Y Nakamura; M Emi
Journal:  Cancer       Date:  1994-10-15       Impact factor: 6.860

6.  Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/cation-independent mannose 6-phosphate receptor in man and mouse.

Authors:  G Laureys; D E Barton; A Ullrich; U Francke
Journal:  Genomics       Date:  1988-10       Impact factor: 5.736

7.  Identification and characterization of proximal 6q deletions in prostate cancer.

Authors:  K A Cooney; J C Wetzel; C M Consolino; K J Wojno
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

8.  Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia.

Authors:  S Takeuchi; M Koike; T Seriu; C R Bartram; M Schrappe; A Reiter; S Park; H E Taub; I Kubonishi; I Miyoshi; H P Koeffler
Journal:  Cancer Res       Date:  1998-06-15       Impact factor: 12.701

9.  Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.

Authors:  I Ito; M Yoshimoto; T Iwase; S Watanabe; T Katagiri; Y Harada; F Kasumi; S Yasuda; T Mitomi; M Emi
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

10.  Loss of heterozygosity of the oestrogen receptor gene in breast cancer.

Authors:  H Iwase; J M Greenman; D M Barnes; L Bobrow; S Hodgson; C G Mathew
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more
  9 in total

Review 1.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

2.  BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma.

Authors:  Christopher S Williams; Baolin Zhang; J Joshua Smith; Ashwath Jayagopal; Caitlyn W Barrett; Christopher Pino; Patricia Russ; Sai H Presley; DunFa Peng; Daniel O Rosenblatt; Frederick R Haselton; Jin-Long Yang; M Kay Washington; Xi Chen; Steven Eschrich; Timothy J Yeatman; Wael El-Rifai; R Daniel Beauchamp; Min S Chang
Journal:  J Clin Invest       Date:  2011-09-12       Impact factor: 14.808

3.  A major lung cancer susceptibility locus maps to chromosome 6q23-25.

Authors:  J E Bailey-Wilson; C I Amos; S M Pinney; G M Petersen; M de Andrade; J S Wiest; P Fain; A G Schwartz; M You; W Franklin; C Klein; A Gazdar; H Rothschild; D Mandal; T Coons; J Slusser; J Lee; C Gaba; E Kupert; A Perez; X Zhou; D Zeng; Q Liu; Q Zhang; D Seminara; J Minna; M W Anderson
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

4.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

5.  Chromosome 6 suffers frequent and multiple aberrations in thymoma.

Authors:  Masayoshi Inoue; Alexander Marx; Andreas Zettl; Philipp Ströbel; Hans-Konrad Müller-Hermelink; Petr Starostik
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

6.  Cyclin C is a haploinsufficient tumour suppressor.

Authors:  Na Li; Anne Fassl; Joel Chick; Hiroyuki Inuzuka; Xiaoyu Li; Marc R Mansour; Lijun Liu; Haizhen Wang; Bryan King; Shavali Shaik; Alejandro Gutierrez; Alban Ordureau; Tobias Otto; Taras Kreslavsky; Lukas Baitsch; Leah Bury; Clifford A Meyer; Nan Ke; Kristin A Mulry; Michael J Kluk; Moni Roy; Sunkyu Kim; Xiaowu Zhang; Yan Geng; Agnieszka Zagozdzon; Sarah Jenkinson; Rosemary E Gale; David C Linch; Jean J Zhao; Charles G Mullighan; J Wade Harper; Jon C Aster; Iannis Aifantis; Harald von Boehmer; Steven P Gygi; Wenyi Wei; A Thomas Look; Piotr Sicinski
Journal:  Nat Cell Biol       Date:  2014-10-26       Impact factor: 28.824

7.  Association of allelic losses at 3p25.1, 13q12, or 17p13.3 with poor prognosis in breast cancers with lymph node metastasis.

Authors:  S Haga; M Emi; A Hirano; Y Utada; T Kajiwara; F Akiyama; G Sakamoto; K Takahashi; T Tada; F Kasumi; Y Miki; Y Nakamura
Journal:  Jpn J Cancer Res       Date:  2001-11

8.  Chromosomal Location of Genes Differentially Expressed in Tumor Cells Surviving High-Dose X-ray Irradiation: A Preliminary Study on Radio-Fragile Sites.

Authors:  Kaori Tsutsumi; Moe Masuda; Hiroyuki Date
Journal:  Curr Issues Mol Biol       Date:  2021-09-08       Impact factor: 2.976

9.  Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.

Authors:  Timothy A Chan; Sabine Glockner; Joo Mi Yi; Wei Chen; Leander Van Neste; Leslie Cope; James G Herman; Victor Velculescu; Kornel E Schuebel; Nita Ahuja; Stephen B Baylin
Journal:  PLoS Med       Date:  2008-05-27       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.